annual FCF:
-$264.74M-$5.32B(-105.24%)Summary
- As of today (May 29, 2025), BNTX annual free cash flow is -$264.74 million, with the most recent change of -$5.32 billion (-105.24%) on December 31, 2024.
- During the last 3 years, BNTX annual FCF has fallen by -$1.14 billion (-130.41%).
- BNTX annual FCF is now -101.90% below its all-time high of $13.94 billion, reached on December 31, 2022.
Performance
BNTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$1.47B-$866.40M(-143.10%)Summary
- As of today (May 29, 2025), BNTX quarterly free cash flow is -$1.47 billion, with the most recent change of -$866.40 million (-143.10%) on March 1, 2025.
- Over the past year, BNTX quarterly FCF has dropped by -$978.51 million (-198.34%).
- BNTX quarterly FCF is now -132.88% below its all-time high of $4.48 billion, reached on March 31, 2022.
Performance
BNTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$1.24B-$978.51M(-369.61%)Summary
- As of today (May 29, 2025), BNTX TTM free cash flow is -$1.24 billion, with the most recent change of -$978.51 million (-369.61%) on March 1, 2025.
- Over the past year, BNTX TTM FCF has dropped by -$6.59 billion (-123.26%).
- BNTX TTM FCF is now -108.92% below its all-time high of $13.94 billion, reached on December 31, 2022.
Performance
BNTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BNTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -105.2% | -198.3% | -123.3% |
| 3 y3 years | -130.4% | -132.9% | -121.6% |
| 5 y5 years | +12.3% | -2013.7% | -317.6% |
BNTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -101.9% | at low | -132.9% | at low | -108.9% | at low |
| 5 y | 5-year | -101.9% | +12.3% | -132.9% | at low | -108.9% | at low |
| alltime | all time | -101.9% | +12.3% | -132.9% | at low | -108.9% | at low |
BNTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.47B(+143.1%) | -$1.24B(+369.6%) |
| Dec 2024 | -$264.74M(-105.2%) | -$605.46M(-21.4%) | -$264.74M(-125.7%) |
| Sep 2024 | - | -$770.16M(-148.0%) | $1.03B(-59.0%) |
| Jun 2024 | - | $1.60B(-425.2%) | $2.51B(-53.0%) |
| Mar 2024 | - | -$493.35M(-171.4%) | $5.34B(+5.8%) |
| Dec 2023 | $5.05B(-63.8%) | $690.54M(-3.2%) | $5.05B(-11.0%) |
| Sep 2023 | - | $713.08M(-83.9%) | $5.67B(-38.6%) |
| Jun 2023 | - | $4.43B(-663.8%) | $9.24B(+6.5%) |
| Mar 2023 | - | -$786.41M(-159.9%) | $8.67B(-37.8%) |
| Dec 2022 | $13.94B(+1500.9%) | $1.31B(-69.3%) | $13.94B(+13.1%) |
| Sep 2022 | - | $4.28B(+10.6%) | $12.33B(+26.0%) |
| Jun 2022 | - | $3.87B(-13.6%) | $9.78B(+69.9%) |
| Mar 2022 | - | $4.48B(-1616.7%) | $5.76B(+561.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $870.47M(-870.7%) | -$295.15M(-117.0%) | $870.47M(-38.4%) |
| Sep 2021 | - | $1.73B(-1202.4%) | $1.41B(-345.9%) |
| Jun 2021 | - | -$157.21M(-61.7%) | -$574.96M(+26.7%) |
| Mar 2021 | - | -$410.31M(-265.5%) | -$453.62M(+301.6%) |
| Dec 2020 | -$112.95M(-62.6%) | $247.93M(-197.1%) | -$112.95M(-74.6%) |
| Sep 2020 | - | -$255.37M(+611.9%) | -$444.24M(+67.1%) |
| Jun 2020 | - | -$35.87M(-48.5%) | -$265.82M(-10.7%) |
| Mar 2020 | - | -$69.63M(-16.5%) | -$297.70M(-1.4%) |
| Dec 2019 | -$301.82M(+102.8%) | -$83.36M(+8.3%) | -$301.82M(+38.2%) |
| Sep 2019 | - | -$76.95M(+13.6%) | -$218.46M(+54.4%) |
| Jun 2019 | - | -$67.76M(-8.1%) | -$141.51M(+91.9%) |
| Mar 2019 | - | -$73.75M | -$73.75M |
| Dec 2018 | -$148.82M(+19.1%) | - | - |
| Dec 2017 | -$124.92M | - | - |
FAQ
- What is BioNTech SE annual free cash flow?
- What is the all time high annual FCF for BioNTech SE?
- What is BioNTech SE annual FCF year-on-year change?
- What is BioNTech SE quarterly free cash flow?
- What is the all time high quarterly FCF for BioNTech SE?
- What is BioNTech SE quarterly FCF year-on-year change?
- What is BioNTech SE TTM free cash flow?
- What is the all time high TTM FCF for BioNTech SE?
- What is BioNTech SE TTM FCF year-on-year change?
What is BioNTech SE annual free cash flow?
The current annual FCF of BNTX is -$264.74M
What is the all time high annual FCF for BioNTech SE?
BioNTech SE all-time high annual free cash flow is $13.94B
What is BioNTech SE annual FCF year-on-year change?
Over the past year, BNTX annual free cash flow has changed by -$5.32B (-105.24%)
What is BioNTech SE quarterly free cash flow?
The current quarterly FCF of BNTX is -$1.47B
What is the all time high quarterly FCF for BioNTech SE?
BioNTech SE all-time high quarterly free cash flow is $4.48B
What is BioNTech SE quarterly FCF year-on-year change?
Over the past year, BNTX quarterly free cash flow has changed by -$978.51M (-198.34%)
What is BioNTech SE TTM free cash flow?
The current TTM FCF of BNTX is -$1.24B
What is the all time high TTM FCF for BioNTech SE?
BioNTech SE all-time high TTM free cash flow is $13.94B
What is BioNTech SE TTM FCF year-on-year change?
Over the past year, BNTX TTM free cash flow has changed by -$6.59B (-123.26%)